מיפג'ין

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

MIFEPRISTONE

Dostupné s:

A. LAPIDOT PHARMACEUTICALS, LTD

ATC kód:

G03XB01

Léková forma:

טבליה

Složení:

MIFEPRISTONE 200 MG

Podání:

פומי

Druh předpisu:

מרשם נדרש

Výrobce:

EXELGYNE LABORATORIES, FRANCE

Terapeutické skupiny:

MIFEPRISTONE

Terapeutické oblasti:

MIFEPRISTONE

Terapeutické indikace:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

Datum autorizace:

2014-07-31